2008
DOI: 10.1590/s1415-47572008000300005
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of the serpin peptidase inhibitor (alpha-1-antitrypsin) PI*S and PI*Z alleles in Brazilian children with liver disease

Abstract: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 (SERPINA1) deficiency is one of the main genetic causes related to liver disease in children. In SERPINA1 deficiency the most frequent SERPINA1 alleles found are the PI*S and PI*Z alleles. We used the polymerase chain reaction and the amplification created restriction site (ACRS) technique to investigate the prevalence of the PI*S and PI*Z alleles in a group of Brazilian children (n = 200) with liver disease and established the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
(22 reference statements)
0
1
0
Order By: Relevance
“…This process is mediated mainly by activated hepatic stellate cells (HSC) undergoing a phenotypic switch from a quiescent vitamin A storing phenotype to a proliferative myofibroblast-like cell [1]. Cirrhosis represents a serious worldwide health care problem and may be caused by genetic disorders [2], viruses [3], toxins [4], auto-immune [5,6], and cholestatic diseases [7]. Liver transplantation is a highly successful treatment for end-stage cirrhosis, with a 5-year survival rate of around 70%.…”
Section: Introductionmentioning
confidence: 99%
“…This process is mediated mainly by activated hepatic stellate cells (HSC) undergoing a phenotypic switch from a quiescent vitamin A storing phenotype to a proliferative myofibroblast-like cell [1]. Cirrhosis represents a serious worldwide health care problem and may be caused by genetic disorders [2], viruses [3], toxins [4], auto-immune [5,6], and cholestatic diseases [7]. Liver transplantation is a highly successful treatment for end-stage cirrhosis, with a 5-year survival rate of around 70%.…”
Section: Introductionmentioning
confidence: 99%